MSB 2.76% $1.76 mesoblast limited

No one asked, but here are my thoughts on the next 12months. -...

  1. 120 Posts.
    lightbulb Created with Sketch. 30
    No one asked, but here are my thoughts on the next 12months.

    - FDA meeting in April, BLA application in May. Would expect to see share price at $1.5.

    - If we're lucky enough to receive a compelling 12 month readout for CLBP in June, then $2 s/p + would be expected.

    - Then the 6 months to round out the year should include a global partner, aGVHD market launch and CHF primary end point.

    Not to mention any developments with Tasly, LVAD direction and unforeseen positives. The Broker reports for $4-$5 could definitely be hit by Christmas.

    A few negative announcements I'm wary of include.

    - The company decides to take up the option on the Kentrgrove finance facilty or new loan agreements as I believe the mounting pile of debt could kill us before lift off if any product delays occur. ( history shows they will )

    - Failed endpoint on CLBP of CHF will demolish us.

    - aGVHD delays or BLA rejection will drop us well below $1 IMO.

    Corrections encouraged.
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Mkt cap ! $944.5M
Open High Low Value Volume
$1.83 $1.85 $1.75 $4.373M 2.459M

Buyers (Bids)

No. Vol. Price($)
1 6243 $1.76

Sellers (Offers)

Price($) Vol. No.
$1.77 1629 1
View Market Depth
Last trade - 16.10pm 18/10/2019 (20 minute delay) ?
-0.050 ( 3.22 %)
Open High Low Volume
$1.83 $1.85 $1.75 215717
Last updated 15.59pm 18/10/2019 (live) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.